These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Autologous muscle-derived cells for the treatment of female stress urinary incontinence: a 2-year follow-up of a Polish investigation. Stangel-Wojcikiewicz K; Jarocha D; Piwowar M; Jach R; Uhl T; Basta A; Majka M Neurourol Urodyn; 2014 Mar; 33(3):324-30. PubMed ID: 23606303 [TBL] [Abstract][Full Text] [Related]
5. Stress urinary incontinence animal models as a tool to study cell-based regenerative therapies targeting the urethral sphincter. Herrera-Imbroda B; Lara MF; Izeta A; Sievert KD; Hart ML Adv Drug Deliv Rev; 2015 Mar; 82-83():106-16. PubMed ID: 25453264 [TBL] [Abstract][Full Text] [Related]
6. Will we ever use stem cells for the treatment of SUI? ICI-RS 2011. Goldman HB; Sievert KD; Damaser MS Neurourol Urodyn; 2012 Mar; 31(3):386-9. PubMed ID: 22431263 [TBL] [Abstract][Full Text] [Related]
7. Bone marrow mesenchymal stromal cell therapy for external urethral sphincter restoration in a rat model of stress urinary incontinence. Corcos J; Loutochin O; Campeau L; Eliopoulos N; Bouchentouf M; Blok B; Galipeau J Neurourol Urodyn; 2011 Mar; 30(3):447-55. PubMed ID: 21412824 [TBL] [Abstract][Full Text] [Related]
8. State of the art of where we are at using stem cells for stress urinary incontinence. Furuta A; Jankowski RJ; Honda M; Pruchnic R; Yoshimura N; Chancellor MB Neurourol Urodyn; 2007; 26(7):966-71. PubMed ID: 17580339 [TBL] [Abstract][Full Text] [Related]
9. Experimental study of therapy of bone marrow mesenchymal stem cells or muscle-like cells/calcium alginate composite gel for the treatment of stress urinary incontinence. Du XW; Wu HL; Zhu YF; Hu JB; Jin F; Lv RP; Sun S; Wang HY; Xu JW Neurourol Urodyn; 2013 Mar; 32(3):281-6. PubMed ID: 22847293 [TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of different surgical procedures for female stress urinary incontinence. Is stem cell implantation the future? Surcel C; Savu C; Chibelean C; Iordache A; Mirvald C; Sinescu I Rom J Morphol Embryol; 2012; 53(1):151-4. PubMed ID: 22395514 [TBL] [Abstract][Full Text] [Related]
12. Stress urinary incontinence and regenerative medicine: is injecting functional cells into the urethra feasible based on current knowledge and future prospects? Aufderklamm S; Aicher WK; Amend B; Stenzl A Curr Opin Urol; 2019 Jul; 29(4):394-399. PubMed ID: 31033573 [TBL] [Abstract][Full Text] [Related]
13. Autologous adipose stem cells in treatment of female stress urinary incontinence: results of a pilot study. Kuismanen K; Sartoneva R; Haimi S; Mannerström B; Tomás E; Miettinen S; Nieminen K Stem Cells Transl Med; 2014 Aug; 3(8):936-41. PubMed ID: 24985079 [TBL] [Abstract][Full Text] [Related]
17. Can maximum urethral closure pressure (MUCP) be used to predict outcome of surgical treatment of stress urinary incontinence? Harris N; Swithinbank L; Hayek SA; Yang Q; Abrams P Neurourol Urodyn; 2011 Nov; 30(8):1609-12. PubMed ID: 21780164 [TBL] [Abstract][Full Text] [Related]
19. Multiple doses of stem cells maintain urethral function in a model of neuromuscular injury resulting in stress urinary incontinence. Janssen K; Lin DL; Hanzlicek B; Deng K; Balog BM; van der Vaart CH; Damaser MS Am J Physiol Renal Physiol; 2019 Oct; 317(4):F1047-F1057. PubMed ID: 31411077 [TBL] [Abstract][Full Text] [Related]
20. Advances in stem cell therapy for male stress urinary incontinence. Gallo F; Ninotta G; Schenone M; Cortese P; Giberti C Expert Opin Biol Ther; 2019 Apr; 19(4):293-300. PubMed ID: 30709326 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]